Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Nema Health | 2024 | Series A | $14.5M | New York |
| Petfolk | 2024 | Series C | $36.0M | Charlotte |
| BBOT | 2024 | Venture - Series Unknown | $200.0M | Palo Alto |
| Presidio Medical | 2023 | Series C | $72.0M | South San Francisco |
| Epic Sciences | 2023 | Series G | $24.0M | La Jolla |
| Foghorn Therapeutics | 2026 | Post-IPO Equity | $50.0M | Cambridge |
| LetsGetChecked | 2025 | Series F | $165.0M | Atlanta |
| CareMax | 2022 | Post-IPO Equity | $1.0M | Miami |
| Perceive Biotherapeutics | 2023 | Series B | $78.0M | South San Francisco |
| Voyager Therapeutics | 2024 | Post-IPO Equity | $100.0M | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Nema Health | Series A | $14.5M | New York, United States |
| 52 | Petfolk | Series C | $36.0M | Charlotte, United States |
| 53 | BBOT | Venture - Series Unknown | $200.0M | Palo Alto, United States |
| 54 | Presidio Medical | Series C | $72.0M | South San Francisco, United States |
| 55 | Epic Sciences | Series G | $24.0M | La Jolla, United States |
| 56 | Foghorn Therapeutics | Post-IPO Equity | $50.0M | Cambridge, United States |
| 57 | LetsGetChecked | Series F | $165.0M | Atlanta, United States |
| 58 | CareMax | Post-IPO Equity | $1.0M | Miami, United States |
| 59 | Perceive Biotherapeutics | Series B | $78.0M | South San Francisco, United States |
| 60 | Voyager Therapeutics | Post-IPO Equity | $100.0M | Cambridge, United States |
Nema provides comprehensive trauma care administered by PTSD-trained therapists.
Petfolk provides modern veterinary care through in-person and virtual services.
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.
Presidio Medical is a medtech company that develops a transformational neuromodulation platform.
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing.
CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors.
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Veterinary Practice Partners partners with veterinarians and their teams to enhance their ability to provide companion animal care.
Appello Pharmaceuticals is a preclinical-stage company focused on CNS disorders.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Liquid Wire is dedicated to merging electronics into the physical world through a range of dynamically stretchable and flexible circuits.
Ascend helps make and sell gene therapy treatments. We know a lot about how to create and share these special medicines.
Cortica provides neurological therapies for children with autism and other developmental differences.
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
BlinkRx is a prescription access platform that connects patients to branded medications, ensuring transparent pricing and home delivery.
Intus Care develops healthcare analytics platform to improve care and reduce hospitalizations for patients.
Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Lark is a digital health startup that provides virtual care through AI coaching, smart devices, and tele-monitoring.
DeepSight Technology's vision is to reinvent diagnostic imaging.
Deerfield has invested in 160 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Deerfield's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Life Science. The firm invests across 30 different industry categories.
Among tracked funding rounds, Nuvalent received $500.0M in a Post-IPO Secondary round. Deerfield's total known invested capital is $8.0B.
Deerfield's average investment size is $78.0M across its portfolio of 160 companies.
Recent Deerfield portfolio additions include Nema Health, Petfolk, BBOT, Presidio Medical, Epic Sciences. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors